Metlifecare (ASX:MEQ) Other Financing: A$-0.53 Mil (TTM As of Jun. 2020)


What is Metlifecare Other Financing?

Metlifecare ASX:MEQ 4 Other Financing is A$-0.53 Mil as of Jun. 2020. GuruFocus rates ASX:MEQ with a GF Score™ of 4/100. The stock has 8 warning signs investors should review.

Metlifecare's Other Financing for the six months ended in Jun. 2020 was A$1.45 Mil.

Metlifecare's Other Financing for the trailing twelve months (TTM) ended in Jun. 2020 was A$-0.53 Mil.

Metlifecare Other Financing Historical Data

* Premium members only.

The historical data trend for Metlifecare's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metlifecare Other Financing Chart

Metlifecare Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.53 -93.91

Metlifecare Semi-Annual Data
Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.18 -0.35 -1.98 1.45

Metlifecare Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of A$-0.53 Mil mean?
Metlifecare (ASX:MEQ) has a Other Financing of A$-0.53 Mil as of Jun. 2020. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Metlifecare and its competitors.
Is Metlifecare's Other Financing too high?
Metlifecare's current Other Financing is A$-0.53 Mil. Overall, Metlifecare has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metlifecare's Other Financing compare to HCA and DVA?
Metlifecare's Other Financing of A$-0.53 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Metlifecare and its competitors. Metlifecare's current Other Financing is A$-0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metlifecare stock overvalued right now?
Metlifecare (ASX:MEQ) has a current Other Financing of A$-0.53 Mil. The current Other Financing is A$-0.53 Mil. Metlifecare's overall GF Score™ is 4/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Metlifecare (ASX:MEQ), the current Other Financing is A$-0.53 Mil as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metlifecare Business Description

Address 20 Kent Street, Level 4, Newmarket, Auckland, NTL, NZL, 1023
Metlifecare Ltd operates retirement communities throughout New Zealand. It generates revenue from membership fees and rest home, hospital and service, and village fees. Metlifecare's membership fees are paid by residents of independent living units and serviced apartments and allow residents to use common facilities. Its largest single customer is the New Zealand government, which pays fees on behalf of residents eligible for government subsidized elderly care. The majority of Metlifecare's retirement villages are located in Auckland.